Cargando…

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment

Benznidazole (BZ) tablets are the currently prescribed treatment for Chagas disease. However, BZ presents limited efficacy and a prolonged treatment regimen with dose-dependent side effects. The design and development of new BZ subcutaneous (SC) implants based on the biodegradable poly-ɛ-caprolacton...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzeti, Ana Lia, Gonçalves, Karolina R., Boasquívis, Patrícia Ferreira, Barbosa, Jamile, Pereira, Bruno G., Soeiro, Maria de Nazaré Correia, Mosqueira, Vanessa Carla Furtado, Bahia, Maria Terezinha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147077/ https://www.ncbi.nlm.nih.gov/pubmed/37111612 http://dx.doi.org/10.3390/pharmaceutics15041126

Ejemplares similares

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2013)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
por: Assíria Fontes Martins, Tassiane, et al.
Publicado: (2015)

Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2018)

Review on Experimental Treatment Strategies Against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2021)

Crystallization of Poly(ε-caprolactone) in Poly(vinylidene fluoride)/Poly(ε-caprolactone) Blend
por: Kong, Yang, et al.
Publicado: (2017)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity
por: Spósito, Pollyanna Álvaro, et al.
Publicado: (2017)

Preparation and in vitro characterization of retinoic acid-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles
por: Shakiba, Ebrahim, et al.
Publicado: (2017)

The Application of Polycaprolactone Scaffolds with Poly(ε-caprolactone)–Poly(ethylene glycol)–Poly(ε-caprolactone) Loaded on Kidney Cell Culture
por: Sun, Junyu, et al.
Publicado: (2022)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

Enzymatic Degradation of Star Poly(ε-Caprolactone) with Different Central Units
por: Blackwell, Catherine J., et al.
Publicado: (2018)

Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors
por: Niu, Yunfei, et al.
Publicado: (2014)

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
por: Gontijo, Maria Katarine Costa Lucas, et al.
Publicado: (2020)

Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018)

Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017)

Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Orthogonal Templating Control of the Crystallisation of Poly(ε-Caprolactone)
por: Mitchell, Geoffrey R., et al.
Publicado: (2018)

Preparation and characterization of polylactide/poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) hybrid fibers for potential application in bone tissue engineering
por: Wang, YueLong, et al.
Publicado: (2014)

Fibrous Materials Made of Poly(ε-caprolactone)/Poly(ethylene oxide)-b-Poly(ε-caprolactone) Blends Support Neural Stem Cells Differentiation
por: Fernández, Daniel, et al.
Publicado: (2019)

Neuronal Parasitism, Early Myenteric Neurons Depopulation and Continuous Axonal Networking Damage as Underlying Mechanisms of the Experimental Intestinal Chagas' Disease
por: Ricci, Mayra Fernanda, et al.
Publicado: (2020)

Biodegradable In Situ Gel-Forming Controlled Drug Delivery System Based on Thermosensitive Poly(ε-caprolactone)-Poly(ethylene glycol)-Poly(ε-caprolactone) Hydrogel
por: Khodaverdi, Elham, et al.
Publicado: (2012)

Properties of Electrospun Nanofibers of Multi-Block Copolymers of [Poly-ε-caprolactone-b-poly(tetrahydrofuran-co-ε-caprolactone)](m) Synthesized by Janus Polymerization
por: Shah, Muhammad Ijaz, et al.
Publicado: (2017)

Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity
por: Prashant, Chandravilas Keshvan, et al.
Publicado: (2014)

Cinnamyl-Modified Polyglycidol/Poly(ε-Caprolactone) Block Copolymer Nanocarriers for Enhanced Encapsulation and Prolonged Release of Cannabidiol
por: Toncheva-Moncheva, Natalia, et al.
Publicado: (2023)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
por: Fragata-Filho, Abilio Augusto, et al.
Publicado: (2016)

The Drug-Loaded Electrospun Poly(ε-Caprolactone) Mats for Therapeutic Application
por: Opálková Šišková, Alena, et al.
Publicado: (2021)

Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Formulation, and Evaluation of Pentoxifylline-Loaded Poly(ε-caprolactone) Microspheres
por: Tamizharasi, S., et al.
Publicado: (2008)

Precise Synthesis, Properties, and Structures of Cyclic Poly(ε-caprolactone)s
por: Xiang, Li, et al.
Publicado: (2018)

Remote Outcomes with Poly-ε-Caprolactone Aortic Grafts in Rats
por: Dokuchaeva, Anna A., et al.
Publicado: (2023)

Sustained Release of Vascular Endothelial Growth Factor from Poly(ε-caprolactone-PEG-ε-caprolactone)-b-Poly(l-lactide) Multiblock Copolymer Microspheres
por: Scheiner, Karina C., et al.
Publicado: (2019)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease
por: Rial, Marcela S., et al.
Publicado: (2017)

Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity [Corrigendum]
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c8qbien28ad3bkg1ph952ld34s